Biomedical Consulting International, Inc has extensive experience in the development of preclinical product development strategies and in the design of nonclinical animal studies to support human clinical studies. BCI can provide guidance and assistance in: the selection of a nonclinical testing facility; the design of the nonclinical study; the review of draft nonclinical study reports to ensure consistency across the nonclinical development program. The leadership and experience of BCI’s consultants can enable the most cost effective and the shortest timeline possible to support new IND, CTA or IDE submissions.

Biomedical Consultants International, Inc also offers nonclinical (pharmacology and toxicology) consulting services, either on an as needed basis or as part of a comprehensive development program plan.